Earnings Call · Q2 FY2024·2024-08-09

Q2 24EPS +55.88%·Rev n/aQ1 24EPS +21.13%·Rev n/aQ4 23EPS +9.86%·Rev n/aQ3 23EPS +2.06%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Mike Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — President, Clinical Diagnostics

Alexey Aleshin — General Manager of Oncology and Chief Medical Officer

+7.3%1d on move date+5.0% vs SPY3d+14.8%5d+18.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access